Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | AmeriHealth | Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing AidsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-049 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Blinatumomab (Blincyto)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-058 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Bioimpedance for the Detection of LymphedemaPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-052A-48ADA05C01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Biofeedback TherapyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-010 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility CampusPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-037 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Bevacizumab (Avastin) and Related Biosimilars For Oncologic UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-072 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Belimumab (Benlysta) for Intravenous UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-057 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Belantamab mafodotin-blmf (Blenrep)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-192 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis or Recurrent Acute RhinosinusitisPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-100 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Axatilimab-csfr (Niktimvo) for Intravenous UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-180 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Avelumab (Bavencio)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-122 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Autonomic Nervous System TestingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-027 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-005 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Auricular ProsthesesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-068 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-127F-7F5FC3D7DA | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-085 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of GlaucomaPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-105K-FB14E7269D | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Application and Removal of TattoosPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-072 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Apos biomechanical shoe systemPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-070 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Apheresis TherapyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-001 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ankle-Foot/Knee-Ankle-Foot OrthosisPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-010 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Anifrolumab-fnia (Saphnelo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-140 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint ManagementPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA01-008 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Amivantamab-vmjw (Rybrevant) and Amivantamab and hyaluronidase-lpuj (Rybrevant Faspro)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-148 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) MonitoringPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-026 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) DevicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-005 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Alpha-1 Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-050 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Allergy ImmunotherapyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-055 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Alglucosidase alfa (e.g., Lumizyme), Avalglucosidase alfa-ngpt (Nexviazyme ), Cipaglucosidase alfa-atga (Pombiliti )PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-036 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Alemtuzumab (Lemtrada)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-015E-2AECB00C21 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Air Ambulance ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA12-007 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-033 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ado-Trastuzumab Emtansine (Kadcyla)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-066 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | ADAMTS13, recombinant-krhn (Adzynma)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-171 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Acute Care Facility Inpatient TransfersPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA12-003B-E0F622FFAA | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | AcupuncturePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA12-004 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | AbortionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-010 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ablation of Lung TumorsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-052 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Abatacept (Orencia) for Injection for Intravenous UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-028 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Zolbetuximab-clzb (Vyloy)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-36 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Zenocutuzumab-zbco (Bizengri)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-38 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Zanidatamab-hrii (Ziihera)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-39 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | X-rays Associated with Fractures in the Office SettingPayerPolicy · AMERIHEALTH-COMMERCIAL-00-03-09 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Bioengineered Skin SubstitutesPayerPolicy · AMERIHEALTH-COMMERCIAL-11-08-20 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Wireless Capsule Endoscopy for Gastrointestinal (GI) DisordersPayerPolicy · AMERIHEALTH-COMMERCIAL-07-05-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Wheelchair Options and AccessoriesPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-67 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Wheelchair Cushions and SeatingPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-55 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Voretigene Neparvovec-rzyl (Luxturna)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-44 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | VeriStrat Testing for Targeted Therapy in Non-Small Cell Lung CancerPayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-49 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ventricular Assist Devices (VADs)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-02-16 | New policy |
|---|